학술논문
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
Document Type
Article
Source
In The Lancet Diabetes & Endocrinology September 2023 11(9):644-656
Subject
Language
ISSN
2213-8587